期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Frontiers in Cellular and Infection Microbiology LetPub Score 7.4
50 ratings
Rate
Reputation 8.1 Influence 6.4 Speed 9.0 | ||||||||||||||||||||||||||||
期刊簡稱 | FRONT CELL INFECT MI | ||||||||||||||||||||||||||||
ISSN | 2235-2988 | ||||||||||||||||||||||||||||
h-index | 53 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 4.30%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://journal.frontiersin.org/journal/cellular-and-infection-microbiology | ||||||||||||||||||||||||||||
在線稿件提交 | http://www.frontiersin.org/submission/submissioninfo.aspx | ||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||
出版商 | Frontiers Media S.A. | ||||||||||||||||||||||||||||
主題領域 | IMMUNOLOGY | ||||||||||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||||||
每年文章數 | 1343每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 99.55% | ||||||||||||||||||||||||||||
OA Related Info | APC: Yes( USD3295; ) APC waiver:Check Notes Other charges: No Keywords: microbial pathogenesis、infectious diseases、pathogen-host interactions、microbiome、clinical microbiology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2235-2988%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 14 Weeks | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 下一頁 末頁 (頁 | |
[Frontiers in Cellular and Infection Microbiology] 的評論 | 撰寫評論 |
作者: 裴裴丶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-08 16:43:26 評論於 Have you encountered this status during the EA stage? NO ACTION IS REQUIRED FROM YOU Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers. Review is ongoing.(0) 讚! | 裴裴丶 |
作者: 裴裴丶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-08 16:38:11 評論於 The review is ongoing 15 days after submission. Does this mean it is likely to be rejected soon?(0) 讚! | 裴裴丶 |
作者: Lily919 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-06 20:01:06 評論於 Mine too, it's been half a month and still haven't been assigned an editor! Very confused!(0) 讚! | Lily919 |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-23 14:10:15 評論於 The time for editors to assign and complete the review is relatively long, and the journal's cycle is about 14 weeks. Please be patient and pay attention to the status of the journal.(0) 讚! | Adelaide Lawson |
作者: 通幽筠竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-08 17:08:05 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Emphasis on research direction: Helicobacter pylori; sharing of cell death experience: will report back when successful, thank you to all forum members. Date Updates 08 Jul 2024 (15:51:17) Article accepted for publication. 05 Jul 2024 (17:48:49) Review of Review Editor 2 finalized. (17:40:09) Corresponding Author Fafeng Cheng re-submitted manuscript. 04 Jul 2024 (15:03:48) Interactive review forum activated automatically. 29 Jun 2024 (15:03:44) Review of Review Editor 3 is finalized. 13 Apr 2024 (06:15:44) Corresponding Author Fafeng Cheng submitted manuscript.(0) 讚! | 通幽筠竹 |
作者: 小白一枚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-08 12:56:33 評論於 I also submitted to this section, but it has been half a month and I still haven't been assigned an editor. How about you?(0) 讚! | 小白一枚 |
作者: fei83 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-25 16:25:53 評論於 One month after submission, the initial review also requires submission. I don't know if there are too many co-authors on the paper, or if the journal has been stricter in its authorship verification recently. Luckily, I have supporting materials, so once they are provided, we can move on to the next review stage.(0) 讚! | fei83 |
作者: 江南芸姝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-10 22:32:37 評論於 I am also a gut microbiota manuscript, it has been submitted for over a month and has not been assigned an editor yet. Is this normal? Should I follow up?(0) 讚! | 江南芸姝 |
作者: 霸王奇略 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-13 23:04:36 評論於 In the Initial Validation phase, the editor requests "evidence that different members of the author group have participated in writing the manuscript." This could be emails exchanged among team members before submission, chat application messages, or manuscript annotations from published reviews. Have you encountered this situation before? Looking for guidance from experienced researchers!(0) 讚! | 霸王奇略 |
作者: 紫萍小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-27 14:17:09 評論於 Hello, do we have to wait for all the reviewers to respond before we can start revising and submitting?(0) 讚! | 紫萍小娘子 |
作者: 紫萍小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 09:04:09 評論於 Hello, I am also an independent review. How long will this take?(0) 讚! | 紫萍小娘子 |
作者: Raul 領域: 医学 審稿時間: 5.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-12-25 12:04:56 評論於 27 Nov 2023 Article accepted for publication. 22 Nov 2023 Review of Review Editor 1 finalized. 15 Nov 2023 Review of Review Editor 2 finalized. Re-submitted manuscript. 06 Nov 2023 Interactive review forum activated automatically. 21 Aug 2023 Submitting(0) 讚! | Raul |
作者: 德云小生 領域: 农林科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-09-25 16:06:09 評論於 Received date: 24 Aug 2023 Editorial assignment start date: 25 Aug 2023 Independent review start date: 04 Sep 2023 Interactive review activated date: 13 Sep 2023 Review finalized date: 19 Sep 2023 Final validation date: 25 Sep 2023 Accepted on 25 Sep 2023(51) 讚! | 德云小生 |
作者: 德云小生 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-25 14:12:26 評論於 Received date: 24 Aug 2023 Editorial assignment start date: 25 Aug 2023 Independent review start date: 04 Sep 2023 Interactive review activated date: 13 Sep 2023 Review finalized date: 19 Sep 2023 Final validation date: 23 Sep 2023(25) 讚! | 德云小生 |
作者: 德云小生 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-16 16:24:21 評論於 Submitted a review article, Reviewer 1 provided minor revisions, recommended for publication after modifications, and shortly after the editor initiated interactive review. Currently, there is only one reviewer. I don't understand what is going on(60) 讚! | 德云小生 |
作者: 拂柳孟州 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-25 11:22:51 評論於 Review speed: 1.0 | Submission hit rate: 95.0 Experience sharing: wu(0) 讚! | 拂柳孟州 |
作者: 凤凰院秋瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-24 09:36:37 評論於 Review speed: 3.0 Emphasis research direction: Intestinal microbiota Experience sharing: Submitted on May 20, received first reviewer comments on August 2, received second reviewer comments on August 5 and finalized, interactive review on August 11, submitted response and revised manuscript on August 19, entered review finalized stage on August 20, received acceptance email on August 24(0) 讚! | 凤凰院秋瑶 |
作者: Sabina Gresham 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-04 21:32:20 評論於 Why would there be such an operation?(0) 讚! | Sabina Gresham |
作者: 东风红凤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-09 14:58:59 評論於 Review speed: 1.0 | Submission hit rate: 95.0 Research focus: Tumor Experience sharing: As a guest editor, I have opened a special issue on "New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy" in the Frontiers in Cellular Infection Microbiology (IF6.073) journal, and submissions are now open. If you have relevant manuscripts on this topic, please feel free to submit. After submission, I will handle the manuscript promptly and select the reviewers recommended by you at the time of submission to improve the manuscript processing and acceptance speed(0) 讚! | 东风红凤 |
作者: Raul 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-04-04 15:32:47 評論於 What is the opinion of the first reviewer? Was it accepted or rejected? It is said that the rejection rate of this journal is quite high this year. Looking at it, from July last year to April this year, they have already published over 1500 articles, which is a huge number.(0) 讚! | Raul |
作者: 方岳霖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-04 00:13:03 評論於 4.4 review2, rejected, rating: 2(0) 讚! | 方岳霖 |
作者: Raul 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-03-29 11:35:55 評論於 23 Mar 2023: Article accepted for publication. 16 Mar 2023: Review of Review Editor 2 finalized. 11 Mar 2023: Re-submitted manuscript. 26 Feb 2023: Interactive review forum activated automatically. 16 Feb 2023: Review of Reviewer 1 is finalized. 30 Jan 2023: Submitting.(0) 讚! | Raul |
作者: 方岳霖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-24 00:54:50 評論於 3.8t投稿 - 3.8t submission 3.11EA - 3.11EA 3.21IR - 3.21IR The following will probably be a long wait. Only one reviewer has accepted the review and requested for recommended reviewers. ··················(0) 讚! | 方岳霖 |
作者: 南川忆风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-23 17:10:34 評論於 The manuscript has been received, but it took more than ten days to find reviewers. Finally, after three reviewers agreed, it took one month and 20 days in total. The manuscript is a clinical prediction model(0) 讚! | 南川忆风 |
作者: 长安靖蕊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-15 20:51:55 評論於 Do I need to pay a layout fee?(0) 讚! | 长安靖蕊 |
首頁 上一頁 1 2 3 4 5 6 下一頁 末頁 (頁 |
Contact us